Anastasia Myskina isn’t accusing Iga Swiatek and Jannik Sinner of anything or questioning the explanations they gave in their doping cases but the 2004 French Open champion would just like to know why some other players in similar situations received a bigger suspension.
After twice testing positive for anabolic steroid clostebol, the ITIA said that the top-ranked ATP player proved that he bore no fault or negligence for what happened and therefore there was no reason to suspend him.
On the other side, the Polish tennis star was positive for trimetazidine and she accepted a one-month for it. However, it should be noted that Swiatek proved that her positive test was caused by the contamination of a regulated non-prescription melatonin medication.
In both cases, it was determined that there was no intention to dope. But some aren’t accepting it and believe that double standards were involved in how those cases were handled.
Myskina shares her take on the Swiatek, Sinner doping situations
“I don’t welcome categorical attitudes towards them. I want to know all the details of the cases. There are various doping cases similar to these, but with different ‘sentences.’ This is what I don’t understand. Why do some miss a month, while others miss several years? Regardless of all the factors, they remain great players,” the former world No. 2 said, according to Championat.
Anastasia Myskina© Team by Anastasia Myskina/Instagram – Fair Use
Meanwhile, Sinner could still get suspended in early 2025 if the WADA’s appeal to the CAS is successful.
When it comes to the four-time French Open champion, she served 22 days during her provisional suspension so her one-month ban expired this past Wednesday.
“At first I couldn’t understand how that was even possible and where it had come from. It turns out testing revealed historically lowest levels of trimetazidine, a substance I’ve never heard about before. I don’t think I even knew it existed. I have never encountered it, nor did people around me,” Swiatek claimed last week.
Tennis World USA